Intuitive Surgical (ISRG) Stock Buyback History
TTM buyback yield 2.09% · Shareholder yield (TTM) 2.09%.
TTM buyback yield
2.09%
Shareholder yield (TTM)
2.09%
5Y share count change
0.5%
TTM buyback spend
$3.42B
SBC coverage (TTM)
4.21x
YoY change in spend
N/A
5Y CAGR of spend
+76.4%
Peak year (2022)
$2.61B
Cumulative spend
$11.25B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Intuitive Surgical (ISRG) repurchased about $3.42B of stock over the trailing twelve months.
- Diluted share count is roughly flat (0.5%) over the last ~5 fiscal years — buybacks are offsetting dilution but not shrinking the float.
- TTM buyback ÷ stock-based-comp ratio of 4.21× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +76.4% per year over the latest 5-year window.
- TTM repurchases used about 121% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $2.30B | $788.20M | $1.51B | 0.36B | 0.2% | 1.14% |
| 2024 | $0.00 | $676.80M | −$676.80M | 0.36B | 1.3% | — |
| 2023 | $416.30M | $598.20M | −$181.90M | 0.36B | -1.3% | 0.35% |
| 2022 | $2.61B | $513.20M | $2.09B | 0.36B | -1.0% | 2.80% |
| 2021 | $0.00 | $449.20M | −$449.20M | 0.37B | 1.4% | — |
| 2020 | $134.30M | $395.40M | −$261.10M | 0.36B | 0.7% | 0.14% |
| 2019 | $269.50M | $335.80M | −$66.30M | 0.36B | 0.6% | 0.39% |
| 2018 | $0.00 | $261.20M | −$261.20M | 0.36B | 2.1% | — |
| 2017 | $2.27B | $209.10M | $2.06B | 0.35B | -1.4% | 5.55% |
| 2016 | $42.50M | $177.60M | −$135.10M | 0.35B | 3.7% | 0.17% |
| 2015 | $183.70M | $167.90M | $15.80M | 0.34B | 0.5% | 0.90% |
| 2014 | $1.00B | $168.90M | $831.10M | 0.34B | -6.0% | 5.21% |
| 2013 | $1.11B | $168.90M | $940.30M | 0.36B | -2.4% | 7.45% |
| 2012 | $238.30M | $153.30M | $85.00M | 0.37B | 2.2% | 1.21% |
| 2011 | $331.80M | $136.40M | $195.40M | 0.36B | -0.2% | 1.83% |
| 2010 | $198.60M | $117.60M | $81.00M | 0.36B | 2.8% | 1.97% |
| 2009 | $150.00M | $96.98M | $53.02M | 0.35B | -1.8% | 1.29% |
| 2008 | $0.00 | $0.00 | $0.00 | 0.36B | 2.4% | — |
| 2007 | $0.00 | $36.29M | −$36.29M | 0.35B | 2.4% | — |
| 2006 | $0.00 | $25.26M | −$25.26M | 0.34B | 1.6% | — |
| 2005 | $72.00K | $4.75M | −$4.68M | 0.34B | 7.2% | 0.00% |
| 2004 | $0.00 | $0.00 | $0.00 | 0.31B | 48.0% | — |
| 2003 | $6.00K | $700.00K | −$694.00K | 0.21B | 29.6% | 0.00% |
| 2002 | $2.00K | $2.57M | −$2.57M | 0.16B | 1.8% | 0.00% |
| 2001 | $65.00K | $0.00 | $65.00K | 0.16B | 50.5% | 0.02% |
| 2000 | $20.00K | $0.00 | $20.00K | 0.11B | 391.9% | — |
| 1999 | $43.00K | $0.00 | $43.00K | 0.02B | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Intuitive Surgical (ISRG) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Intuitive Surgical (ISRG)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Intuitive Surgical (ISRG)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $2.30B | — | +$2.30B | ||
| 2024 | $0 | -100.0% | -$416.30M | ||
| 2023 | $416.30M | -84.0% | -$2.19B | ||
| 2022 | $2.61B | — | +$2.61B | ||
| 2021 | $0 | -100.0% | -$134.30M | ||
| 2020 | $134.30M | -50.2% | -$135.20M | ||
| 2019 | $269.50M | — | +$269.50M | ||
| 2018 | $0 | -100.0% | -$2.27B | ||
| 2017 | $2.27B | +5250.6% | +$2.23B | ||
| 2016 | $42.50M | -76.9% | -$141.20M | ||
| 2015 | $183.70M | -81.6% | -$816.30M | ||
| 2014 | $1.00B | -9.8% | -$109.20M | ||
| 2013 | $1.11B | +365.5% | +$870.90M | ||
| 2012 | $238.30M | -28.2% | -$93.50M | ||
| 2011 | $331.80M | +67.1% | +$133.20M | ||
| 2010 | $198.60M | +32.4% | +$48.60M | ||
| 2009 | $150.00M | — | +$150.00M | ||
| 2008 | $0 | — | $0 | ||
| 2007 | $0 | — | $0 | ||
| 2006 | $0 | -100.0% | -$72,000 | ||
| 2005 | $72,000 | — | +$72,000 | ||
| 2004 | $0 | -100.0% | -$6,000 | ||
| 2003 | $6,000 | +200.0% | +$4,000 | ||
| 2002 | $2,000 | -96.9% | -$63,000 | ||
| 2001 | $65,000 | +225.0% | +$45,000 | ||
| 2000 | $20,000 | -53.5% | -$23,000 | ||
| 1999 | $43,000 | — | — |
Intuitive Surgical (ISRG) most recent annual buyback spend stands at $2.30B (2025).
Intuitive Surgical buyback spend compound annual growth for the 2020–2025 (5 years) window is +76.4%, with the latest reading among the more recent periods of the dataset.
Intuitive Surgical buyback spend peaked at $2.61B in 2022; the latest annual figure is $2.30B in 2025 (12.0% below peak).
The dataset's maximum buyback spend sits at $2.61B (2022); the minimum reading of $0 dates to 2004.
Within Healthcare, Intuitive Surgical (ISRG) ranks 5th among 8 peers we track. The peer median for buyback spend is $2.75B.
Intuitive Surgical Buyback Spend 2025: $2.30B
Intuitive Surgical buyback spend in 2025 was $2.30B.
Intuitive Surgical Buyback Spend 2024: $0
Intuitive Surgical buyback spend in 2024 was $0, plunged 100.0% below 2023.
Intuitive Surgical Buyback Spend 2023: $416.30M
Intuitive Surgical buyback spend in 2023 was $416.30M, plunged 84.0% below 2022.
Intuitive Surgical Buyback Spend 2022: $2.61B
Intuitive Surgical buyback spend in 2022 was $2.61B.
Intuitive Surgical Buyback Spend 2021: $0
Intuitive Surgical buyback spend in 2021 was $0.
See more financial history for Intuitive Surgical (ISRG).
Sector peers by buyback spend
Companies in the same sector as Intuitive Surgical, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 4.21×.
Capital allocation mix
How Intuitive Surgical splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $2.83B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Intuitive Surgical's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Intuitive Surgical buy back its own stock?
Yes, Intuitive Surgical (ISRG) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Intuitive Surgical spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $3.42B (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Intuitive Surgical's buyback yield?
TTM buyback yield is about 2.09% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Intuitive Surgical's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 2.09% combined (TTM-based where available).
Is Intuitive Surgical diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Intuitive Surgical's share count changed?
Diluted weighted average shares changed by about 0.5% over roughly five fiscal years (annual income statement data).
What is Intuitive Surgical's buyback spend?
Latest reported buyback spend for Intuitive Surgical (ISRG) is $3.42B (period ending March 31, 2026).
What is the long-term growth rate of Intuitive Surgical buyback spend?
Intuitive Surgical (ISRG) buyback spend compound annual growth rate is +76.4% over the most recent 5 years available.
When did Intuitive Surgical buyback spend hit its highest annual value?
Intuitive Surgical buyback spend reached its highest annual value of $2.61B in 2022.
What was Intuitive Surgical buyback spend in 2024?
Intuitive Surgical (ISRG) buyback spend in 2024 was $0.
What was Intuitive Surgical buyback spend in 2025?
Intuitive Surgical (ISRG) buyback spend in 2025 was $2.30B.
Explore more
ISRG Overview
Company profile, financial tools, and key metrics
ISRG Revenue Counter
Earns $335.56 every second. See per minute, hour, and day.
ISRG Earnings Counter
Earns $94.47 per second net profit. See per minute, hour, and day.
ISRG Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
ISRG What If Invested
What if you had invested $1,000? See historical returns from any date.
ISRG How It Makes Money
Discover visual breakdown of $10.58B in revenue — where it comes from and where it goes.
ISRG Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ISRG Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ISRG Daily Price Character
Explosive · 50.8% historical win rate (green days). Streaks & record days.
ISRG Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
ISRG Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.